Concepedia

Bernard P. Murray

BP

45

Publications

2.6K

Citations

27

H-Index

1987

Active since

Affiliations

Gilead Sciences (United States)(Current)

London Postgraduate Medical and Dental Education

University of California, San Francisco

Merck & Co., Inc., Rahway, NJ, USA (United States)

Washington State University Spokane

Bernard P. Murray is an author at Gilead Sciences (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1987–2024

45

Publications

45

JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib

Paqui G. Través, Bernard P. Murray, Federico Campigotto et al. · Annals of the Rheumatic Diseases · 2021 · 307 citations · Full text

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

Eve‐Irene Lepist, Xuexiang Zhang, Hao Jia et al. · Kidney International · 2014 · 239 citations · Full text

Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity

Anita Mathias, Polina German, Bernard P. Murray et al. · Clinical Pharmacology & Therapeutics · 2009 · 206 citations

Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer

Lianhong Xu, Hongtao Liu, Bernard P. Murray et al. · ACS Medicinal Chemistry Letters · 2010 · 200 citations

, , +19

Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340, <i>In Vitro</i>

Eve‐Irene Lepist, Truc K. Phan, Anupma Roy et al. · Antimicrobial Agents and Chemotherapy · 2012 · 134 citations · Full text

, , +18

Rows per page

1–5 of 45